Abstract: A process of producing an asymmetric membrane of multicomponent polyimide. The process includes the steps of (1) preparing a multicomponent polyimide blend solution by mixing a polyimide component A having a number-averaged polymerization index NA and a polyimide component B having a number-averaged polymerization index NB, wherein NA and NB satisfies equation 1: 2.35×NA?2.09<NB<450×NA?1.12??1 (2) subjecting the multicomponent polyimide blend solution to further polymerization and imidation reaction, and (3) causing a phase inversion in the resulting multicomponent polyimide blend solution to form an asymmetric membrane. The polyimide component A is raw materials of polyimide A containing a fluorine atom in the chemical structure thereof and/or a polymerization and imidation reaction product of the raw materials. The polyimide component B is raw materials of polyimide B and/or a polymerization and imidation reaction product of the raw materials.

Abstract: A compound represented by the formula (I), an optically active isomer thereof, or a pharmaceutical acceptable salt thereof: wherein each R1 represents hydrogen atom or the like; X represents oxygen atom or the like; A represents a C3-C7 cycloalkyl group, a C6-C10 aryl group or a heterocyclic group; R6 represents a halogen atom or the like; s represents 0 or an integer of 1 to 5; Q represents a pyridine ring which may be substituted or pyrimidine ring; and R2 represents hydrogen atom or the like, which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).

Abstract: In a packet transmission method and device, when a received packet is written in a packet buffer, an address of the packet buffer is stored as a read address for each destination corresponding to a physical port and storing information of the received packet. The read address of a destination designated by the received packet information is read and saved when the received packet is read out of the packet buffer in accordance with a scheduling control. Then, the saved read address is taken out in accordance with an arbitration control and a received packet corresponding to the saved read address is read from the packet buffer.

Abstract: A process of producing an asymmetric membrane of multicomponent polyimide. The process includes the steps of (1) preparing a multicomponent polyimide blend solution by mixing a polyimide component A having a number-averaged polymerization index NA and a polyimide component B having a number-averaged polymerization index NB, wherein NA and NB satisfies equation 1: 2.35×NA?2.09<NB<450×NA?1.12??1 (2) subjecting the multicomponent polyimide blend solution to further polymerization and imidation reaction, and (3) causing a phase inversion in the resulting multicomponent polyimide blend solution to form an asymmetric membrane. The polyimide component A is raw materials of polyimide A containing a fluorine atom in the chemical structure thereof and/or a polymerization and imidation reaction product of the raw materials. The polyimide component B is raw materials of polyimide B and/or a polymerization and imidation reaction product of the raw materials.

Abstract: A data communication apparatus has a data retainer, a retain state manager, a guaranteed bandwidth manager, a surplus bandwidth manager managing outputting of output data having a destination retained in the data retainer to an output line on a per-destination basis when the output data is outputted to the output line with the use of a surplus bandwidth that is a surplus over a sum of guaranteed bandwidths, and a scheduler scheduling outputting of data retained in the data retainer to the output line, based on results of managements by the guaranteed bandwidth manager and the surplus bandwidth manager and a retain state managed by the retain state manager.

Abstract: In a communication apparatus, a write controller writes received data in a temporary memory which serves as short-time storage. A read controller reads data out of the temporary memory. A discard controller controls discard operation of the data read out of the temporary memory.

Abstract: A polyimide film made of a multicomponent polyimide comprising two or more different polyimide components including (A) a polyimide component A being raw materials of a polyimide A and/or a polyimidation product of the raw materials and (B) a polyimide component B being raw materials of a polyimide B and/or a polyimidation product of the raw materials. The polyimide components A and B are different, for example, such that the absolute difference between solubility parameter SPA of the polyimide A and solubility parameter SPB of the polyimide B, |SPB?SPA|, is 0.5 MPa1/2 or more. The polyimide film has markedly modified surface properties as compared with a polyimide film in which all the same raw materials as used in the film of the invention are randomly bonded to one another.

Abstract: A compound represented by the formula (I), an optically active isomer thereof, or a pharmaceutical acceptable salt thereof: wherein R1 represents a C1-C12 alkyl; R2 represents a hydrogen atom or the like; R3 represents a halogen or the like; q represents an integer of 1 to 7; R4 represents a halogen or the like; p represents 0 or an integer of 1 to 5; R5 represents a C6-C10 aryl, a heterocycle or the like; and X represents oxygen, NH, or the like, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).

Abstract: The present invention is directed to a substituted phenylethynylgold-nitrogen-containing heterocyclic carbene complex represented by the formula (1) or (2): wherein L represents a nitrogen-containing heterocyclic carbene ligand, and X represents an alkyl group, a cycloalkyl group, an aryl group, an aralkyl group, a heterocyclic group, an alkoxy group, an aryloxy group, an alkylmercapto group, an arylmercapto group or a substituted amino group; and one or a plural number of hydrogen atoms on the carbon atom(s) of X are independently optionally replaced by a halogen atom, an alkyl group, a cycloalkyl group, an alkenyl group, an aryl group, an aralkyl group, an alkoxy group, an aryloxy group, an alkylmercapto group, an arylmercapto group or a substituted amino group.

Abstract: A compound represented by the formula (I), an optically active isomer thereof, or a pharmaceutical acceptable salt thereof: wherein R2 represents a hydrogen or the like; R3 represents methyl group or the like; R20 represents a halogen atom or the like; q represents an integer of 0 to 3; Z represent nitrogen atom, CH, or the like; R4 represents hydrogen or the like; R5 represents hydrogen or the like; R6 represents a substituted alkyloxy and the like; p represents an integer of 0 to 3; X represents bond, CH2, oxygen atom, NH, or the like; any one or more of R5 and R6, R5 and R4, R6 and R4, X and R5, X and R4, X and R6, and R6 and R6 may combine to each other to form a ring, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).

Abstract: A compound represented by the formula (I), an optically active isomer thereof, or a pharmaceutical acceptable salt thereof: wherein X represents CH or N; represents a C1-C12 alkyl; R2 represents a hydrogen atom, or the like; R? represents a C1-C6 alkyl or the like; q represents 0 or an integer of 1 to 7; Y represents a C1-C6 alkyl or the like; p represents 0 or an integer of 1 to 5; R represents a 2,3-dihydroindolyl or the like, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).

Abstract: The present invention provides a substituted ethynyl gold-nitrogen containing heterocyclic carbene complex represented by the general formula (1): wherein L represents a nitrogen containing heterocyclic carbene ligand; and X represents an alkyl group, a cycloalkyl group, an aryl group, an aralkyl group or a heterocyclic group; in which one or more hydrogen atoms on the carbon atom(s) of X may be replaced by a halogen atom, an alkyl group, a cycloalkyl group, an alkenyl group, an aryl group, an aralkyl group, an alkoxy group, an aryloxy group, a dialkylamino group, an acyl group or an arylcarbonyl group; and, when more than one hydrogen atom on the carbon atom(s) of X is replaced by the alkyl group, the alkenyl group, the aryl group, the aralkyl group, the alkoxy group, the aryloxy group, the dialkylamino group, the acyl group or the arylcarbonyl group, the adjacent groups may be bonded together to form a ring, a method for preparing the same, and an organic electroluminescent device comprising the substi

Abstract: A pyrimidone derivative having tau protein kinase 1 inhibitory activity which is represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof; useful for prventive and/or therapeutic treatment of diseass such as neurodegenerative diseases (e.g. Alzheimer disease); wherein Q represents CH or nitrogen atom; R represents a C1-C12 alkyl group; the ring of Formula (I): represents piperazine ring or piperidine ring; each X independently represents a C1-C8 alkyl group, an optionally partially hydrogenated C6-C10 aryl ring, an indan ring or the like; m represents an integer of 1 to 3; each independently represents a halogen atom, a hydroxy group, a cyano group, a C1-C6 alkyl group or the like; n represents an integer of 0 to 8; when X and Y or two Y groups are attached on the same carbon atom, they may combine to each other to form a C2-C6 alkylene group.

Abstract: A process for wet pulverizing mesoporous silica particles while a surfactant exists in mesopores, and mesoporous silica particles having an average particle diameter of 1 ?m or less, wherein the volume of mesopores having a diameter of 2 to 50 nm is 0.7 mL/g or more and the geometric standard deviation of a mesopore distribution is 2.0 or less. Mesoporous silica particles having a particle diameter in a submicron order can be obtained at a high yield without causing the marked collapse of mesopores and can be produced efficiently by using an ordinary pulverizer and safely by using an aqueous medium. The mesoporous silica particles having an average particle diameter of 1 ?m or less are useful as an ink absorbent for ink jet recording paper, low-dielectric film, catalyst support, separating agent, adsorbent and medical carrier for medicines.

Abstract: In a packet transmission method and device, when a received packet is written in a packet buffer, an address of the packet buffer is stored as a read address for each destination corresponding to a physical port and storing information of the received packet. The read address of a destination designated by the received packet information is read and saved when the received packet is read out of the packet buffer in accordance with a scheduling control. Then, the saved read address is taken out in accordance with an arbitration control and a received packet corresponding to the saved read address is read from the packet buffer.

Abstract: An asymmetric hollow-fiber gas separation membrane is made of a soluble aromatic polyimide that is composed of a specific repeating unit. The tetracarboxylic acid component of the unit has a diphenylhexafluoropropane structure and a biphenyl structure. The diamine component of the unit essentially contains diaminobenzoic acids and any of diaminodibenzothiophenes, diaminodibenzothiophene=5,5-dioxides, diaminothioxanthene-10,10-diones, and diaminothioxanthene-9,10,10-triones.

Abstract: The present invention is a technology concerning a reception pointer processing in an SDH transmission system. The objects of the invention are to identify automatically a frame size (frame composition) of the received transmission frame in the SDH (SONET) transmission system and to perform flexibly and rapidly a reception pointer processing corresponding to the frame size.

Abstract: An aligned metal-particle film, in which metal particles are aligned in a polymer as a layer with a certain interval in parallel with a substrate is disclosed. The aligned metal-particle film is manufactured by forming a polymer film containing a metal component on a reflecting substrate; and irradiating the polymer film with light at a particular wavelength, whereby metal particles are aligned in parallel with the substrate in the polymer.

Abstract: The present invention relates to an asymmetric hollow-fiber gas separation membrane made of a polyimide having a specific repeating unit, an improved tensile elongation at break of 15% or more as a hollow-fiber membrane itself, an oxygen gas permeation rate (P?O2) of 4.0×10?5 cm3 (STP)/cm2·sec·cmHg or more and a gas ratio of permeation rate of oxygen to nitrogen (P?O2/P?N2) of 4 or more that are measured at 50° C., a gas separation method and a gas separation membrane module using the asymmetric hollow-fiber gas separation membrane. In addition, the present invention relates to an asymmetric hollow-fiber gas separation membrane obtained by heat-treating the asymmetric hollow-fiber gas separation membrane at a maximum temperature of from 350 to 450° C. The asymmetric hollow-fiber gas separation membrane has sufficient mechanical strength even after the heat-treatment at a maximum temperature of from 350 to 450° C.

Abstract: A porous insulating film comprising a highly heat resistant resin film having a fine porous structure with a mean pore size of 0.01-5 ?m in at least the center of the film, and a porosity of 15-80%. A laminate is prepared by forming a heat resistant adhesive layer or a conductive metal layer or an inorganic or metal substrate on one or both sides of the porous insulating film or by forming an inorganic or metal substrate on one side of the porous insulating film and a conductive metal layer on the other side.